Table 3.
Incidence, n (%) | n = 19 |
---|---|
Any AE | 9 (47) |
Any AE considered at least possibly related to study medication | 0 |
Any AE leading to discontinuation | 0 |
Any SAE | 4 (21) |
Any grade 3 or 4 AE | 1 (5) |
Most common AEs (occurring in > 1 woman) | |
Chorioamnionitis | 3 (16) |
Vaginal discharge | 2 (11) |
AE adverse event, SAE serious adverse event